Crossmark

Immunogenicity and safety of the CoronaVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults: comparison of different vaccines

Crossref DOI link: https://doi.org/10.1007/s10787-022-01089-6

Published Online: 2022-10-25

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Batıbay, Sevilay https://orcid.org/0000-0002-6286-3632
Ulucaköy, Rezan Koçak

Günendi, Zafer

Fidan, Işıl

Bozdayı, Gülendam

Göğüş, Feride Nur
Funding

Funding for this research was provided by:

TLAR
License Information

Text and Data Mining valid from 2022-10-25

Version of Record valid from 2022-10-25
More Information

Article History

Received: 19 July 2022

Accepted: 16 October 2022

First Online: 25 October 2022

Declarations

:

: All authors declare that they have no conflict of interest.

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below